Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

INTETOOLS

Financiado

Cerrado

Repurposing of CAST Systems as Next-Generation Tools for Genome Engineering of M...

Repurposing of CAST Systems as Next-Generation Tools for Genome Engineering of Mammalian Cells Genome editing using RNA-guided CRISPR-Cas nucleases (Clustered Regularly Interspaced Short Palindromic Repeats that associate with CRISPR associated proteins) has radically altered life sciences, enabling genome manipulation in l... ver más

31/10/2028

UCPH

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

KOBENHAVNS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-07-03

ERC-2022-ADG: ERC ADVANCED GRANTS Scope:Objectives

I+D

Cerrada hace 2 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UCPH

2.48M€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

BROADCAST Molecular mechanisms, functions and applications of RNA-gui... 1M€ Cerrado

CRISPAIR Study of the interplay between CRISPR interference and DNA r... 1M€ Cerrado

dCas9 Dissection of the mammalian transcription termination mechan... 183K€ Cerrado

CRISPR2.0 Microbial genome defence pathways from molecular mechanisms... 2M€ Cerrado

SCRIBE RNA-based gene writing in human cells 2M€ Cerrado

DUALgRENP A DUAL gRNA system for functional assessment of ENhancers in... 183K€ Cerrado

Duración del proyecto: 63 meses Fecha Inicio: 2023-07-03
Fecha Fin: 2028-10-31

Líder del proyecto

KOBENHAVNS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Genome editing using RNA-guided CRISPR-Cas nucleases (Clustered Regularly Interspaced Short Palindromic Repeats that associate with CRISPR associated proteins) has radically altered life sciences, enabling genome manipulation in living organisms. However, their use is limited by dependence on DNA Damage Response (DDR), which restricts genome editing to dividing cells. Further, these nucleases cannot handle DNA cargos large enough to harbour regulatory DNA circuitry, thus precluding genome engineering. In INTETOOLS, I will overcome these limitations by dissecting and repurposing CRISPR Associated Transposon (CAST) systems into genome engineering tools. CASTs are naturally occurring prokaryotic protein–RNA machineries consisting of an inactive CRISPR effector complex, which associate with Tn7 family transposons to insert large DNA cargos. Knowledge of their molecular mechanisms is scarce, which prevents their practical application in genome engineering. Accordingly, in Objective 1, I will investigate the architecture of different CASTs to obtain fundamental knowledge of their RNA-guided integration. I will then use this knowledge in Objective 2, to dissect their mechanism underpinnings whereby CRISPR-Cas complexes associate with transposition complexes to insert with nucleotide accuracy DNA cargos. This will inform Objective 3, where I will design new CAST tools that will allow RNA-guided transposition in eukaryotic genomes. These revamped CASTs will be capable of inserting large DNAs with high precision, harbouring regulatory regions into eukaryotic genomes, enabling genome engineering in eukaryotes. I will test the redesigned CASTs in mammalian cell lines and at the organismal level by rescuing the eyeless mutant phenotype in Drosophila melanogaster. INTETOOLS will catalyse a conceptual leap propelling the field into a new era of genome engineering, with major biomedical and biotechnological applications especially in synthetic biology.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores